Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,184,625
+$20,906,214 QoQ
Shares Held
1,620,743
+3.3% QoQ
Ownership
0.654%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#31
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $348,973,073 across 50 Biotechnology names. EXEL ranks #1 (25.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
1,620,743 | $88,184,625 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 3 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 5 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,169 | $10,018,546 | |
| 7 | VCEL |
Vericel Corp
|
170,272 | $7,575,400 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
17,229 | $6,403,502 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,184,625 | 1,620,743 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $67,278,411 | 1,568,627 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $52,074,641 | 1,188,105 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,554,363 | 61,849 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,045,487 | 69,090 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $2,552,907 | 69,147 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $2,471,958 | 74,233 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,963,999 | 75,684 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,776,275 | 79,051 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,968,444 | 209,374 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,816,519 | 242,456 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,765,191 | 172,320 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,606,195 | 84,050 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,660,117 | 85,529 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,378,124 | 85,918 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,006,317 | 127,954 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,751,940 | 84,147 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,874,287 | 82,677 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,525,009 | 83,425 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,740,879 | 82,350 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,515,776 | 83,193 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $1,873,659 | 82,942 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,630,205 | 81,226 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,034,753 | 83,221 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,011,062 | 84,712 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,367,147 | 79,393 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||